Investing Profile

Krishna Yeshwant

VCInvestor

Partner at GV

gv.com/team/krishna-yeshwant/Boston, Massachusetts

Your Intro Paths to Krishna Yeshwant

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Krishna is a member of

Stanford University Network

703 CONNECTIONS

Harvard Business School Network

507 CONNECTIONS

Google Network

476 CONNECTIONS

GV Network

29 CONNECTIONS

Harvard Medical School Network

27 CONNECTIONS

Find Krishna Yeshwant on

Current Investing Position

GV (Google Ventures) Partner

Investment Range

$250K - $50.0M

Sweet Spot

$25.0M

Investments On Record

123

Current Fund Size

$8B

Krishna Yeshwant is on these Sector & Stage Rankings

Consumer Health (Series A)Security (Series A)BioTech (Series A)Boston / New England Social Networks (Series A)

Krishna Yeshwant's Investments On Record (63)

Company	StageDateRound Size	Total Raised
Isomorphic Labs	Series BMay 2026$2.1B Series AMar 2025$600M	$2.7B
Co-investors: Joshua Kushner (Thrive Capital)
Parabilis Medicines	Series FJan 2026$310M Series EMar 2024$150M Series DNov 2022$180M Series CJan 2021$110M Series BMay 2018$66M	$800M
Co-investors: Elena Viboch (General Catalyst), Corey Goodman (venBio), Jake Simson (RA Capital), Thilo Schroeder (Nextech Invest)
Gate Bioscience	Series BNov 2025$65M Series ANov 2023$60M	$130M
Co-investors: Scott Biller (GV (Google Ventures)), Vineeta Agarwala (Andreessen Horowitz), Clare Ozawa (Versant Ventures), Jay Parrish (ARCH Venture Partners)
Counsel Health	Series AOct 2025$25M	$36M
Co-investors: Julie Yoo (Andreessen Horowitz), Vivien Ho (Pear VC), Jay Rughani (Andreessen Horowitz), David Reshef (GV (Google Ventures))
Sprinter Health	Series BMay 2025$55M Series AOct 2021$33M	$93M
Co-investors: Hemant Taneja (General Catalyst), Julie Yoo (Andreessen Horowitz), Holly Maloney McConnell (General Catalyst), Rich Wong (Accel), Kevin Lin, Tony Xu
Perceive Pharma	Series AFeb 2025$15M	$15M
Co-investors: Cameron Wheeler (Deerfield Management)
Clear Labs	Series DJan 2025$30M Series CMay 2021$60M Series UnknownMay 2020$21M Series BDec 2016$16M	$170M
Co-investors: Aydin Senkut (Felicis Ventures), Greg Yap (Menlo Ventures), Chris Sklarin (Alumni Ventures ), Kyle Kurpinski (Tencent Holdings), Karl Handelsman (Codon Capital), Miguel Valls (Alta Life Sciences)
Cala Health	Series CDec 2024$50M Series CMay 2019$50M Series BFeb 2016$18M	$200M
Co-investors: Laura Rippy (Alumni Ventures ), Nicole Walker (Arboretum Ventures), John Kuelper (Ascension Ventures)